Research Article
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
Table 3
Parameters selected for analysis.
| | Parameter | Selected for analyses |
| | Period of reported results (minimum follow-up period) | (i) BOLT: 18-month update (18 months of follow-up)
(ii) ERIVANCE: 12-month update (21 months of follow-up) |
| | Efficacy outcomes | (i) ORR
(ii) DOR
(iii) PFS |
| | Matching variables | (i) Prior BCC radiotherapy
(ii) Prior BCC surgery |
|
|
BCC: basal cell carcinoma; DOR: duration of response; ORR: objective response rate; PFS: progression-free survival.
|
